- Advertisement -spot_img
Friday, June 21, 2024

Top 10 Biotech Solution Providers 2021

The life sciences sector has played a critical role amid the COVID19 pandemic. To address the global crisis, traditional competitors have teamed up to accelerate research and create the fastest new vaccine ever. Governments, healthcare systems, payers, retail pharmacies, and non-profits are now working with the industry to ensure comprehensive distribution and management.

COVID19 has fundamentally changed our private and professional lives. As companies work remotely, workplaces are transforming from virtual workstations to new forms of external collaboration. Life sciences companies are more geared towards the individual needs of their employees and promote well-being. This growing connectivity and fuzzy geographic boundaries are also expanding the talent pool and access to skills.

With the introduction of this “new normal”, digitization broadens the horizon of new possibilities in the life sciences sector. Newly defined work environments; change in health care; and innovative collaborations to increase efficiency are just a few examples that lead to this unprecedented change, which is supported by technological advances. As pharmaceutical innovations save the world, now is an opportunity for biopharmaceutical and medical technology companies to keep this momentum going.

 Corporate finance for digital health reached a record $ 21.6 billion worldwide in 2020, a 103% increase over 2019. One thing is clear: with the help of digital health tools, virtual care it can fundamentally transform access to healthcare and transform an improved one. care enables the experience. Digitization in the life sciences sector has also led to an increase in new point-of-care systems, digital pharmacy setups, and easy and efficient access to healthcare.

 In our Top 10 Biotech Solution Providers, we examine the various opportunities for change within the industry, the changes that are likely to continue, and what can be rethought and improved. It also examines different scenarios for stakeholders to analyze how these changes can better transform the industry.

iNDX.Ai

Management:

Mohan Uttarwar

Designation:

CEO

Headquarters:

Cupertino, CA

Website:

Indx.ai

iNDEX AI is a highly motivated team of Entrepreneurs, Doctors, Engineers and Data Scientists with the mission to develop innovative software products, help collaborators find a Cure-for-Cancer and make a societal impact, globally.

BrightInsight

Management:

Ferry Tamtoro

Designation:

Co-founder & CEO

Headquarters:

San Jose, CA

Website:

brightinsight.com

BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Their medical-grade Internet of Things (IoT) platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement.

Crscube

Management:

Kim Kidon

Designation:

CEO

Headquarters:

Seoul, South Koria

Website:

crscube.io

CRScube was established in February 2010 by a group of dedicated industry professionals seeking to provide industry-leading eClinical solutions.

Cytek

Management:

Wenbin Jiang Ph.D.

Designation:

CEO

Headquarters:

Fremont, CA 

Website:

Cytek.com

Cytek Biosciences is committed to providing comprehensive solutions that enable scientists to rapidly and efficiently obtain deep biological insights through high quality, high parametric datasets. The company is on a mission to advance cancer and cell biology research using a powerful cell analysis technique called full spectrum flow cytometry.

Framework MI

Management:

Danielle Lydon

Designation:

CEO

Headquarters:

Cincinnati, OH

Website:

frameworkmi.org

Framework MI, Inc., based in Cincinnati Ohio, provides custom software, including revenue cycle solutions, “Big Data,” audit, workflow, reporting, analytics, and a host of other products and consulting services to healthcare organizations/providers across a wide spectrum of the healthcare continuum, (IDN, Hospitals, Physicians, Pharmacies, Payors, Revenue Cycle Vendors, Drug Manufacturers, etc.)

Golden Helix

Management:

Dr. Andreas Scherer

Designation:

CEO

Headquarters:

Bozeman, MT

Website:

goldenhelix.com

A global bioinformatics firm that develops and sells an industry-leading clinical solution.

Leukocare AG

Management:

Michael Scholl

Designation:

CEO

Headquarters:

Munich, Germany

Website:

leukocare.com

LEUKOCARE is a leading provider of technologies for biological functionalization of medical devices, as well as the stabilization and protection of proteins and biological molecules in biopharmaceutical formulations in order to ensure safety, to extend shelf-life and to enable terminal sterilization.

PathAI

Management:

Andrew H. Beck, MD PhD

Designation:

Co-founder & CEO

Headquarters:

Bostan, MA

Website:

pathai.com

PathAI's mission is to improve patient outcomes with AI-powered pathology. Thier platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.

Pluristem

Management:

Nitsan Halevy

Designation:

Chief Medical Officer

Headquarters:

Haifa, Israel

Website:

pluristem.com

Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, hematological disorders and exposure to radiation.

Thrive Bioscience

Management:

Thomas Forest Farb-Horch

Designation:

CEO

Headquarters:

Wakefield, MA

Website:

thrivebio.com

Thrive Bioscience, located in the Boston area, offers customers a family of instruments and software that provide imaging, analytics, and automation for reproducible adherent cell culture. Our products empower biologists by combining advanced software, microscopy, and robotics, to acquire, organize, and analyze images of all their cells.

Translate »